EBS:NYSE
Emergent Biosolutions Inc
US$6,98
arrow_downward
-1,13%(-0,080) 1D
US$6,90
arrow_downward
-1,15% (-0,080)bedtimeAfter hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
US$7,08
High
US$7,33
Low
US$6,95
Mkt. cap
357,89 ລ້ານ
Avg. vol.
1,16 ລ້ານ
Volume
951,24 ພັນ
52-wk high
US$14,06
52-wk low
US$4,36
EPS
US$-3,51
Beta
2,28
Shares outstanding
51,27 ລ້ານ
No. of employees
900
Open
US$7,08
High
US$7,33
Low
US$6,95
Mkt. cap
357,89 ລ້ານ
Avg. vol.
1,16 ລ້ານ
Volume
951,24 ພັນ
52-wk high
US$14,06
52-wk low
US$4,36
EPS
US$-3,51
Beta
2,28
Shares outstanding
51,27 ລ້ານ
No. of employees
900
News stories
From web sources and news partners
Yahoo Finance
·
32 ນາທີກ່ອນ
Big Banks Kick Off Q3 Earnings With S&P 500 Near Records — Strategists Flag What Could Move Markets
www.marketscreener.com
·
1 ຊົ່ວໂມງກ່ອນ
Nextdoor Holdings, Inc. Primary Exchange Listing will Change to Nasdaq Capital Market from New York Stock Exchange
Cryptonews.net
·
24 ນາທີກ່ອນ
Evernorth Hits Nasdaq With 473 Million XRP as XRPN Trading Begins
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees900
Founded5 ກ.ຍ. 1998
HeadquartersRockville, ແມຣີແລນ, ສະຫະລັດ
SectorBiotechnology
Websiteemergentbiosolutions.com